Sunday, 20 September 2026European Markets

OREGE Stock Bearish By 18% In The Last 5 Sessions

Loading stream...

orege (orege.pa), a company listed on the cac 40 index, has recently experienced significant financial shifts. over the course of five trading sessions, orege saw an 18% drop, from eur0.68 to eur0.55. this decrease in value has occurred simultaneously with a larger upward trend on the cac 40. the cac 40, during this time, has had its index climb slightly by 1.02% to eur7,343.96.

orege's troubling market performance

orege specializes in designing and operating municipal and industrial sludge treatment solutions. despite this niche industry, its share price has been on a steady decline since its 52-week high of eur0.82. as of last friday, its shares closed at eur0.59, a concerning 28.05% drop from the peak point.

orege's financial difficulties

adding to the concern around orege's financial stability, the earnings per share (eps), a measure of profitability, fell to eur-0.12 over the past twelve months. this negative eps is indicative of the financial difficulties that the company is enduring. additionally, a subsequent drop in the share price only further underscores these issues.

orege's continued operations

despite these poor stock market results, orege continues to persist in its industry. the company offers services related to installation and commissioning, operator training, warranty extensions, maintenance support, and process line optimization. therefore, it is apparent that the organization is striving to improve its current standing.

investor considerations

as orege's stock endures this period of turbulence, it is critical for potential investors to be vigilant of any sudden shifts in value. before venturing into this investment, the associated risks must be considered, especially those tied to an organization with negative earnings. this consideration is particularly pertinent for those wishing to invest in markets that are currently downtrending.

more news about orege (orege.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com